Comparison Study of the Effect of Erlotinib as a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy. (2018). Ibn AL-Haitham Journal For Pure and Applied Sciences, 31(3), 63-69. https://doi.org/10.30526/31.3.2011